Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Journal of Lipid Research

Volumn 41, Issue 2, 2000, Pages 195-198

  Lütjohann, Dieter ^a,b   Papassotiropoulos, Andreas ^a   Björkhem, Ingemar ^b   Locatelli, Sandra ^a   Bagli, Metin ^a   Oehring, Randi D ^a   Schlegel, Uwe ^a   Jessen, Frank ^a   Rao, Marie Luise ^a   Von Bergmann, Klaus ^a   Heun, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apolipoprotein E; Blood brain barrier; Brain cholesterol; Cell membrane; Depression; Hippocampus; Isotope dilution mass spectrometry; Senile plaques

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL DERIVATIVE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMAN; ISOTOPE DILUTION ASSAY; MALE; MASS SPECTROMETRY; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0343775806     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ball, M. J. 1977. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol. Berl. 37: 111-118.
2. Hyman, B. T., G. W. Van Horsen, A. R. Damasio, and C. L. Barnes. 1984, Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225: 1168-1170.
3. Busser, J., D. S. Geldmacher, and K. Herrup. 1998. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18: 2801-2807.
4. Ignatius, M. J., E. M. Shooter, R. E. Pitas, and R. W. Mahley, 1987. Lipoprotein uptake by neuronal growth tones in vitro. Science. 236: 959-962.
5. Lütjohann, D., O. Breuer, G. Ahlborg, I. Nennesmo, A. Sidén, U. Diczfalusy, and I. Björkhem, 1996, Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA. 93: 9799-9804.
6. Björkhem, I., D. Lütjohann, O. Breuer, A. Sakinis, and A. Wennmalm. 1997. Importance of a novel oxidative mechanism for elimination of brain cholesterol. J. Biol. Chem. 272: 30178-30184.
7. Copeland, J. R., I. A. Davidson, M. E. Dewey, C. Gilmore, H. A. Larkin, C. McWilliam, P. A. Saunders, A. Scott, V. Sharma, and C. Sullivan. 1992. Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br. J. Psychiatry. 161: 230-239.
8. Speck, C. E., W. A. Kukull, D. F. Brenner, J. D. Bowen, W. C. McCormick, L. Teri, M. L. Pfanschmidt, J. D. Thompson, and E. B. Larson. 1995. History of depression as a risk factor for Alzheimer's disease. Epidemiology. 6: 366-369.
9. Alexopoulos, G. S., and R. C. Abrams. 1991. Depression in Alzheimer's disease. Psychiatr. Clin. North. Am. 14: 327-340.
10. Björkhem, I., D. Lütjohann, U. Diczfalusy, L. Stahle, G. Ahlborg, and J. Wahren. 1998. Evidence for a cerebral origin of 24S-hydroxycholesterol in the human circulation. J. Lipid Res. 39: 1594-1600.
11. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak Vance, J. England, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90: 1977-1981.
12. Saunders, A. M., W. J. Strittmatter, D. Schmechel, P. H. St. George Hyslop, M. A. Pericak Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, M. D. Crapper, M. J. Alberts. C. Hulette, B. Crain, D. Goldgaber, and A.D. Roses. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease [see comments]. Neurology. 43: 14157-1472.
13. Pitas, R. E., J. K. Boyles, S. H. Lee, D. Foss, and R. W. Mahley. 1987. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 917: 148-161.
14. Robins, L. N., J. Wing, H. U. Wittchen, J. E. Helzer, T. F. Babor, J. Burke, A. Farmer, A. Jablenski, R. Pickens, D. A. Regier, and et al. 1988. The Composile International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry. 45: 1069-1077.
15. World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, editor, Geneva, Switzerland.
16. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
17. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J. Lipid Res. 31: 545-548.
18. Babiker, A., and U. Diczfalusy. 1998. Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Biophys. Acta. 1392: 333-339.
19. Kölsch, H., D. Lütjohann, A. Tulke, I. Björkhem, and M. L. Rao. 1999. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res. 818: 171-175.
20. Mahley, R. W., T. L. Innerarity, S. C. Rall, and K. H. Weisgraber. 1984. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25: 1277-1294.